Bruce K. Dallas

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Nutanix, Inc. of $575 million aggregate principal amount of its 0% convertible…

Davis Polk advised the joint book-running managers in connection with a $190 million SEC-registered common stock offering of 6,139,515 shares of common stock of Revance Therapeutics,…

Davis Polk advised Comcast Corporation and NBCUniversal Media, LLC in connection with their $5.5 billion exchange offer of new lower-coupon Comcast senior notes for seven series of Comcast…

Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $500 million aggregate principal amount of 2.900% notes due 2027.  Texas Instruments is a…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $288 million public offering of common stock by Juno…

Davis Polk advised the joint book-running managers and the co-managers in connection with the $349.3 million public offering of common stock by Portola Pharmaceuticals, Inc. The…

Davis Polk advised the joint book-running managers and representatives of the underwriters on the $201 million public offering by BeiGene, Ltd. of American Depositary Shares. The ADSs…

Davis Polk advised Comcast Corporation on its $2.5 billion SEC-registered debt offering of 3.150% notes due 2028 and 4.000% notes due 2047.  Comcast is a global media and technology…

Davis Polk advised the joint book-running managers in connection with a $260.8 million SEC-registered offering of 3,622,500 shares of common stock of Loxo Oncology, Inc. The common stock is…

Davis Polk advised Comcast Corporation, Comcast Cable Communications, LLCand NBCUniversal Enterprise, Inc. in connection with the issuance and sale of $1.5 billion aggregate principal…